# Takeda (TAK) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/TAK
## Company Profile
- Ticker: TAK
- Exchange: NYSE
- Sector: Biopharma
- Location: Japan and listed in the U
- Tags: Blood Products, Oncology, CNS
## Stock Data
- Close: 18.1 USD
- Market cap: 47963846158.799995 USD
- Last updated: 2026-10-06
## Business Overview
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
## Why The Stock Is Moving

As of Oct 6, 2026, TAK closed up 1.63% at $18.10. No new same-company headline was identified in the current news window.

## Geographic Base

Takeda is headquartered in Japan and listed in the U.S. market. It sits in global large-cap pharma rather than biotech.

## Business Model

The company generates value through branded medicines, portfolio diversification, and disciplined R&D reinvestment. Investors watch pipeline progress, earnings stability, and geographic breadth.

## Landscape Position

Takeda sits in the top tier of global pharma. It is less binary than biotech, but its pipeline and launch cadence still matter to the market.

## Future Catalysts

- Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.

## Recent News
- 2021-11-16 12:53 EST — [Takeda’s Area Offices in Dubai, United Arab Emirates Certified Sustainable and Inaugurated](https://biopharmsignal.com/news/TAK/takeda-s-area-offices-in-dubai-united-arab-emirates-certified-sustainable-and-in-73cb70b0) — Source: Takeda
- 2021-07-30 09:50 EST — [Takeda and Frazier Healthcare Partners Announce Collaboration to Launch HilleVax, Inc. to Develop Clinical Stage Norovirus Vaccine Candidate](https://biopharmsignal.com/news/TAK/takeda-and-frazier-healthcare-partners-announce-collaboration-to-launch-hillevax-d130e715) — Source: Takeda